Cost pressures and environmental concerns in healthcare are driving reassessment of single-use medical devices, particularly for chronic conditions requiring frequent interventions. For the millions using intermittent catheters long-term, switching to reusable options could dramatically reduce waste and healthcare expenditure while maintaining patient safety.
This 12-month randomized trial involving 578 community-dwelling adults across the UK compared standard single-use catheter protocols against a mixed approach combining reusable and single-use catheters. The primary endpoint measured microbiologically confirmed symptomatic urinary tract infections requiring medical intervention or self-treatment. Results demonstrated non-inferiority for the mixed-use strategy, with UTI rates falling within the pre-specified safety margin of a 2.0 odds ratio threshold.
The findings challenge entrenched medical device practices that prioritize single-use items based on theoretical infection control benefits rather than evidence-based outcomes. For intermittent catheterization—a procedure performed multiple times daily by individuals managing neurogenic bladder or retention issues—this represents a significant paradigm shift. The non-inferiority design strengthens clinical confidence, as it specifically tested whether reusable options perform adequately rather than seeking superiority.
Limitations include the open-label design and potential selection bias among participants willing to try reusable devices. However, the large sample size and real-world community setting enhance generalizability. This evidence may accelerate adoption of sustainable catheter management protocols, potentially reducing both environmental impact and healthcare costs without compromising patient outcomes for this vulnerable population requiring lifelong bladder management.